Search results for “OB Receptor” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 67 patents, we discovered top 19 key players by total patent application. Millennium Pharmaceuticals, Inc., Amgen, Inc., Angiochem, Inc. are dominant in this area. They take 47.76% of the total patent filing.
Millennium Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 12
Amgen, Inc.
California, United States
Patent: 10
Angiochem, Inc.
Quebec, Canada
Patent: 10
Genentech, Inc.
California, United States
Patent: 6
Chiron Corp.
California, United States
Patent: 5
Suven Life Sciences Ltd.
Andhra Pradesh, India
Patent: 4
Firmenich, Inc.
New Jersey, United States
Patent: 3
Merck & Co., Inc.
New Jersey, United States
Patent: 2
Otsuka Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 2
Glaxo Group Ltd.
Hounslow, United Kingdom
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
No data, please try another search term
New Entrants
Order by:
Innovation in recent 5 years
No data, please try another search term
Research Institutions
Order by:
Innovation Intensity
With the analysis among 5 patents, we discovered top 3 universities and scientific research institutions by total patent application.
Australian National University
Australian Capital Territory, Australia
Patent: 1
The University of Sydney
Australia
Patent: 1
The Garvan Institute of Medical Research
New South Wales, Australia
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: